Area of research
Oncology · Cancer Research
Research interest
Research focused on Breast cancer and Chemoradiotherapy, with related work in Head and neck cancer, Clinical endpoint, Docetaxel. Notable publications include 'Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer...', 'Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer', and 'Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103'.
Nivolumab for Patients With High-Risk Oral Leukoplakia
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer
Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103.
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
The PARADIGM trial: A phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC).